Any opinions, findings, conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of NursingAnswers.net.
Treatment of Acute Cholecystitis
In this paper, I am going to talk about a patient I had the chance to assess in the clinical area. I spent one day with this patient where I gave him some of his medications and did a head to toe assessment on him. In this paper, I am going to illustrate briefly his demographics, his chief complaint, his past health history, and I am going to focus on the medication he is taking.
GG is a 49-year-old High school teacher of Mexican descent. He has been admitted to the hospital because of his acute pain in his abdomen and back. When discussing his health history, patient states that he has hypertension and gout. The patient reported no having any prior episodes of pain in his abdomen and his posterior right side. He reported having sudden sharp pain in those areas and cramping. Patient stated he quit smoking two years ago, denies the use of recreational smoke and drinks occasionally, specifically two beers on weekends. He is 5 feet 8 inches tall and weighs 205 pounds; his oral temperature is 99.8, pulse 72, respirations 18, blood pressure 150/82; On physical examination, his abdomen was tender to palpation.
Furthermore, he presented redness, swelling, and tenderness in the metatarsophalangeal joint of the first toe of the right foot. He had a fever has demonstrated by his high temperature, and his labs were abnormal; specifically, his white blood cell count was above average, specifically 12000 units. After this finding, the provider ordered a computed tomography (CT) scan of his abdomen, and the results showed acute cholecystitis. Therefore, the provider ordered two antibiotics to eliminate the infection and pain medications to reduce the patient’s pain.
The patient is currently receiving the following medications: Rocephin (Ceftriaxone) 2 grams intravenous every 24 hours combined with Flagyl (Metronidazole) 500 mg intravenous every 8 hours to get rid of the infection. Tylenol (Acetaminophen) 1000mg orally as needed every 6 hours for his pain combined with Motrin (Ibuprofen) 600mg orally as needed every 6 hours for his pain. On top of this medication’s patient can receive Oxycodone 5 mg orally every 4 hours for his pain if Tylenol and Motrin do not work. The patient had the following home medications, Zyloprim (Allopurinol) 100 mg orally every 12 hours to treat the patient’s gout and Micardis (Telmisartan) 80 mg orally once a day to treat his hypertension.
One of the medications I am going to focus on is an antibiotic GG is currently taking. Specifically, metronidazole. This antibiotic is in the nitroimidazoles family and is used in the treatment of anaerobic infections, in this case for intra-abdominal infections, and it is usually used in conjunction with a cephalosporin, in this case, in fact, it is used together with Ceftriaxone. Its action is to disrupt DNA and protein synthesis in a susceptible organism, and its effect is to kill bacteria. This antibiotic is absorbed about 80% after oral administration and 100% via intravenous. As far as distribution, it is widely distributed into most tissues and fluids. It crosses the placenta and enters fetal circulation rapidly and enters breast milk in concentrations equal to plasma levels. Metrodinazodole is partially metabolized by the liver, partly excreted through urine and a minimal part in the feces (McCuistion, Yeager, Winton, & DiMaggio, 2018, pg.371).
Metronidazole side effects regarding the central nervous system are dizziness, headaches, and with intravenous administration encephalopathy and aseptic meningitis. For the gastrointestinal tract, the most common side effects are abdominal pain, nausea, dry mouth, and vomiting. Regarding the skin, it can cause rashes, urticaria, and skin irritation in general. Three adverse effects that need to be monitored for this drug are seizures, Stevens-Johnson syndrome, and superinfection. Some contraindications for this medicine are hypersensitivity and first-trimester pregnancy, on top of that, it should be used with caution when breastfeeding. Some precautions to have when using this drug are in cases of severe hepatic impairment, history of blood dycriasis, and when receiving corticosteroids. As far as interactions, this drug should not me took at the same time with cimetidine because it could decrease metabolism. Not to be taken with rifampin, which could increase metabolism and reduce effectiveness. Avoid taking it together with warfarin or lithium due to its increased effects of these medications. Furthermore, avoid taking with alcohol this could cause confusion and psychosis ((Vallerand & Sanoski, 2018, p.850).
The administration of this medication can be oral, topical, vaginal, and intravenous like in our case. The maximum dose to be given intravenous is 4 grams in one day for adults, GG is currently taking 500 mg three times a day. Therefore, his dose is within the safe dose. There are no accu- checks with this medication. As far as labs in order to assess the efficacy of the antibiotics we would check his blood results to see if the white blood cells are going down meaning that the infection is diminishing, also we want to check renal and liver function since this specific antibiotic since it can cause liver and renal problems (Vallerand & Sanoski, 2018, p.850).
In the case of GG, this medication is prescribed to cure the infection in his cholecystic. Since his cholecystic is infected, the provider orders this antibiotic to eradicate the bacteria and kill the infection. The provider could have chosen a different class of antibiotics such as Aminopenicillins like amoxicillin, which is excreted unchanged in the bile. In patients with normal biliary function, the concentration of amoxicillin is three times higher in bile than in plasma. For example, the biliary level of ceftriaxone is 28 to 45 times higher than the plasma concentration. The bile concentration remains high even in patients with obstruction of the gallbladder. The combination of ciprofloxacin with metronidazole may be an alternative to amoxicillin/clavulanic acid in patients with mild or moderate ACC and no risk factors for resistance. In this case, the provider preferred a combination of ciprofloxacin and metronidazole. In acute cholecystitis, metronidazole is prescribed in conjunction with other antibiotics; nitroimidazole derivatives are assigned in addition to the antibiotic base suspected mixed aerobic-anaerobic infection as we can see in this specific case metronidazole has been prescribed together with ceftriaxone to increase its action (Fucks, Cossé, & Régimbeau, 2003, para.11).
When giving metronidazole, we need to assess the patient for infections, by checking his vital signs, and appearance of wounds if any, sputum, urine, and stool for infection. Also, we need to check blood; specifically, the white blood cells count at the beginning and during the therapy. Then we need to monitor intake and output and daily weight, especially for patients on sodium restriction. Another essential thing to do is to check the patient periodically for rash due to the possibility of Steven-Johnson syndrome, which is an adverse effect of this medication. Potential nursing diagnoses with this medication can be a risk for infection and diarrhea. When giving this medication the patient needs to be taught to avoid intake of alcoholic beverages, inform patient that the medicine can cause an unpleasant metallic taste and that it can cause dizziness, therefore avoid tasks that require alertness and not be alarmed if urine turns dark. Very important is to notify the provider if a rash occurs. Lastly, the desired outcomes of this medication are the resolution of signs and symptoms of infection (Vallerand & Sanoski, 2018, p.852).
As we already discussed, metronidazole is better to be avoided in the first trimester of pregnancy, Metronidazole crosses the placental barrier, and its effects on the human fetal are not known. Safety and effectiveness in pediatric patients have not been established. In elderly geriatric patients, monitoring for metronidazole associated adverse events is recommended, especially for decreased liver function in geriatric patients can result in increased concentrations of metronidazole that may necessitate adjustment of metronidazole dosage (Vallerand & Sanoski, 2018, p.851).
The other medication I am going to focus on is an anti-inflammatory GG is currently taking. Specifically, Ibuprofen. This medication is a nonsteroidal antiinflammation agent (NSAID)and is used to decrease pain and inflammation. Its action is to inhibit prostaglandin synthesis. This antibiotic is absorbed about 80% after oral administration and 100% via intravenous. As far as distribution, it is widely distributed into most tissues and fluids; however, it does not enter breast milk in significative amounts. Ibuprofen is mostly metabolized by the liver and excreted through the kidneys in a small amount ((Vallerand & Sanoski, 2018, p.666).
Ibuprofen side effects regarding the central nervous system are Drowsiness, dizziness, headache, confusion, insomnia. For the gastrointestinal tract, the most common side effects are gastric distress, nausea, vomiting. It can also cause blurred vision, edema, and tinnitus. Some adverse effects that need to be monitored for this drug are myocardial infarctions, various types of dermatitis, Stevens-Johnson syndrome, and gastrointestinal bleeding. Some contraindications for this medicine are hypersensitivity, active gastrointestinal bleeding, and ulcers. Should be used cautiously with patients that have had a coronary heart bypass. Some precautions to have when using this drug are in cases of severe renal impairment since it can cause nephrotoxicity history and with cardiovascular diseases. As far as interactions, this drug should be avoided when taking warfarin sound, it can Increase bleeding, and with some foods like garlic and herbal supplements such as ginger, gingko, and ginseng. Increased effects with phenytoin, sulfonamides, warfarin, cephalosporins, and decreased effect with aspirin (Vallerand & Sanoski, 2018, p.667).
The administration of this medication can be oral as in our case and intravenous. The maximum dose to be given orally to adults is 3 grams, GG is currently taking 600 mg three times a day. Therefore, his dose is within the safe dose. There are no accu- checks with this medication. Regarding labs, it is critical to check blood urea nitrogen (BUN), creatinine, complete blood count (CBC), and liver function (Vallerand & Sanoski, 2018, p.668).
In the case of GG, this medication is given to decrease the patient’s pain due to his infection. Ibuprofen is a non-steroidal anti-inflammatory drug with anti-inflammatory, analgesic, and antipyretic activity. More in detail, ibuprofen can perform these activities by inhibiting cyclooxygenase (COX). Ibuprofen works by inhibiting COX-2 consequentially preventing the synthesis of prostaglandins responsible for fever, inflammation, and pain. However, it is crucial to point out that ibuprofen is not selective for COX-2; therefore, it is also able to inhibit COX-1. This latter inhibition is at the origin of some of the side effects typical of all non-selective NSAIDs such as gastrointestinal side effects (McCuistion, Yeager, Winton, & DiMaggio, 2018, pg. 311).
Before giving this ibuprofen, we need to obtain a drug and herbal history and report any possible drug-drug or herb-drug interactions. After we have given the medication, we need to assess for GI distress and peripheral edema, which are common side effects of NSAIDs. Report to the provider immediately if the patient has GI discomfort since this is one of the adverse effects of this medication. We need to access for asthma and urticaria as well. Observe the patient for bleeding gums, petechiae, ecchymoses, or black tarry stools. When giving this medication, we need to check labs, specifically, if BUN is elevated, creatine levels and urine output. Since this is a pain medication, we have to re-assess the pain prior and 1-2 hours following noting the type, location, and intensity. When teaching the patient about the medication, we will advise the patient to avoid alcohol when taking NSAIDs. Moreover, we would recommend the patient to consult the doctor if visual disturbances, tinnitus, or rashes appear. Potential nursing diagnoses with this medication can be acute pain. Lastly, the desired outcomes of this medication are decreased in the severity of pain (Vallerand & Sanoski, 2018, p.669).
Ibuprofen is better to be avoided after 30 weeks’ gestation because it may cause premature closure of fetal ductus arteriosis. We need to be careful when using it with our older population since it can increase the risk of adverse reactions secondary to age-related and drug interactions, also need to be closely monitored for decreases in renal and liver function. As far as infant’s safety has not been established for infants under six months (McCuistion, Yeager, Winton, & DiMaggio, 2018, pg. 314).
We looked at the patient’s problem and the treatment he had to cure his acute cholecystitis. We talked about his medications, in particular about antibiotic metronidazole and pain medication, ibuprofen. We discussed in depth the mechanism of action, nursing assessment and lifespan considerations of this medication and the rationale that the provider used to prescribe this medication which helped the patient get better and get discharged from the hospital.
- Electronic Health Record
- Fuks, D., Cossé, C., & Régimbeau, J.-M. (2013). Antibiotic therapy in acute calculous cholecystitis. Journal of Visceral Surgery, 150(1), 3–8. https://doi-org.dax.lib.unf.edu/10.1016/j.jviscsurg.2013.01.004
- McCuistion, L.E., Yeager, J.J., Winton, M.B., & DiMaggio, K. (2018). Pharmacology: A patient-centered nursing process approach (9th ed.). Philadelphia, PA: Saunders.
- Vallerand, A.H., & Sanoski, C.A. (2018). Davis’s drug guide for nurses (16th ed.). Philadelphia, PA: Davis.
Pharmacology Patient Profile
|Date of Birth||02/20/1970||Age||49||Race||Latino||Gender||Male|
|Acute cholecystitis||Concurrent Diagnoses||Acute cholecystitis|
|High school teacher||Members of Household||2|
|x No Yes||If yes, complete information under Military Service on the next page|
Patient Health History
|Reason for Admission||Mid back pain and abdomen pain|
Past or family History of problems in the Following Categories:
|List ALL Medications this patient is taking, giving the entire physician’s order (i.e. Demerol 50 mg IM every 4 hours PRN pain)||Zyloprim 100 mg PO q12 h
Telmisartan 80 mg PO daily
Ceftriaxone 2 g IV q24 h
Metronidazole 500 mg IV q8 h
Acetaminophen 1000mg IV q4 h PRN pain
Ibuprofen 600mg PO q6 h PRN pain
Oxycodone 5mg PO q4h PRN pain if Acetaminophen/Ibuprofen do not work
|Tobacco||X No Yes
|Alcohol|| No X Yes
|Amount:||2 beers on weekends|
|Drugs||X No Yes Type:||Amount:|
|Military Service||X No Yes, Current Yes, Former|
|Branch of Military|
|When and Where Served|
|What do/did you do in the service?|
|How has military service affected you?|
|Did you see combat, enemy fire, or casualties?||No Yes|
|Were you or a buddy wounded, injured, or hospitalized?||No Yes|
|Were you a prisoner of war?||No Yes|
|Chemical (pollution, solvents, etc.)|
|Biological (infectious disease)|
|Physical (radiation, heat, vibration, noise, etc.)|
|When was the exposure?|
|Where was the exposure?|
|How long was the exposure?|
|How concerned are you about the exposure?|
|Stress Reactions/AdjustmentProblems: With respect to your military service, have you|
|Had nightmares about it or thought about it when you did not want to?||No Yes|
|Tried hard not to think about it or went out of your way to avoid situations that reminded you of it?||No Yes|
|Found yourself constantly on guard, watchful, or easily startled?||No Yes|
|Felt numb or detached from others, activities, or your surroundings?||No Yes|
|O = normal X = abnormal
NA = not assessed
|COMMENTS (describe your findings)|
|General Appearance||O||Oriented x4, appropriate grooming, good mood, cooperative appears older than stated age 49.|
|Skin||O||Warm, dry, intact skin|
|Head and Neck||O||Head: Normocephalic, no lumps, no lesions, no tenderness, no trauma.
Neck: Symmetric, supple with full ROM, no pain.
|Cardiovascular||O||Heart sounds normal, no murmurs|
|Chest/Lungs||O||Lungs sound clear and equal|
|Abdomen||X||Extreme tenderness to palpation, unable to palpate or percuss due to tenderness.|
|Musculoskeletal||X||Body joints within normal limits with exception of joints of both ankles and feet. Redness, swelling and tenderness in the metarsophalangeal joint of first toe of right foot. Unable to dorsiflex and extend both feet.|
|Student Name||Bernardini Alessio||Date||07/05/2019||Patient Initials||GG|
|Medication Name & Classification||Dose, Frequency & Route||Mechanism of Action||Major & Common Side Effects||Rationale for this Patient||Nursing Considerations|
Class: Antigout agents
|100 mg orally every 12 hours||Zyloprim is approximately 90% absorbed from the gastrointestinal tract||Ankle, knee, or great toe joint pain stiffness or swelling, rash||Lower serum and urinary uric acid level||Watch for skin rashes and monitor serum uric acid|
Class: Angiotensin receptor blockers
|80 mg orally once a day||Hepatic via conjugation to inactive metabolites||Back pain, sinusitis, and diarrhea||Management of hypertension||Monitor blood pressure; electrolytes, serum creatinine, BUN|
|2 g IV q 24 hours||Inhibit bacterial cell-wall synthesis, bactericidal||Anaphylaxis, superinfection
Headache, dysgeusia, GI distress
Clostridium difficile-associated diarrhea
Increased bleeding, seizures
|Treat the infection||Culture the infected area before cephalosporin therapy is started.
Tell patient to report signs of superinfection.
Observe for hypersensitivity reactions.
|500 mg IV q 8 hours||Disrupts DNA and protein syntheses in bacteria and protozoa||Anaphylaxis, superinfection
Headache, dizziness, insomnia, weakness
Dry mouth, dysgeusia, GI distress
Peripheral neuropathy, seizures
|Treat the infection||Tell patient to report signs of rashes because of the risk for Stevens-Johnson syndrome
Observe for hypersensitivity reactions.
Class: nonsteroidal ant inflammatory
|1000mg PO every 6 hours PRN pain||Inhibits prostaglandin synthesis||Rash, headache, insomnia
Hepatotoxicity, renal failure
|Management of pain||Check liver enzyme tests for abnormalities.
Check serum acetaminophen level if toxicity is suspected.
Class: nonsteroidal ant inflammatory
|600mg PO every 6 hours PRN pain||Inhibits prostaglandin synthesis||Drowsiness, dizziness, headache, confusion, insomnia, dreams, blurred vision, edema, gastric distress and bleeding, tinnitus, dysrhythmias and nephrotoxicity||Management of pain||Observe the patient for bleeding gums, petechiae, ecchymoses, or black tarry stools and
report if patient has GI discomfort.
Class: opioid analgesic
|5mg PO every 6 hours PRN pain||Act on CNS
Suppress pain impulses
|Drowsiness, confusion, depression, blurred vision.GI distress,
|Management of moderate pain||Monitor vital signs frequently to detect respiratory changes.
Check for pupil changes and reaction.
Cite This Work
To export a reference to this article please select a referencing stye below:
Related ServicesView all
DMCA / Removal Request
If you are the original writer of this case study and no longer wish to have your work published on the UKDiss.com website then please: